Title: 3 HOUSE BILL 1079 By: Hildebrant
Official Title: 3 HOUSE BILL 1079 By: Hildebrant
Number of Sections: 1
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 5 sections found

================================================================================

Section 1:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
4
5
6 AS INTRODUCED
7 An Act relating to vaccinations; creating the Vaccine
Transparency and Informed Consent Act; providing the
8 purpose; providing transparency and disclosure
requirements; providing for informed consent
9 standards; providing for civil penalties; requiring
confidentiality of records; providing for
10 severability; providing for codification; and
providing an effective date.
11
12
13
14 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
15 SECTION 1. NEW LAW A new section of law to be codified
16 in the Oklahoma Statutes as Section 7500 of Title 63, unless there
17 is created a duplication in numbering, reads as follows:
18 A. This act shall be known and may be cited as the "Vaccine
19 Transparency and Informed Consent Act".
20 B. The purpose of this act is to ensure transparency in
21 vaccine-related health care practices and to establish informed
22 consent standards by requiring health care providers to disclose
23 comprehensive, evidence-based information regarding vaccines before
24 administration.
Req. No. 11357 Page 1
1 SECTION 2. NEW LAW A new section of law to be codified
2 in the Oklahoma Statutes as Section 7501 of Title 63, unless there
3 is created a duplication in numbering, reads as follows:
4 A. Before administering any vaccine, health care providers
5 shall provide the patient with a written document containing the
6 following:
7 1. A complete list of all ingredients in the vaccine, including
8 active and inactive components, consistent with the Centers for
9 Disease Control and Prevention (CDC) Vaccine Excipient and Media
10 Summary;
11 2. A summary of the testing and development process of the
12 vaccine, including but not limited to, clinical trial phases, study
13 size, and results related to safety and efficacy; and
14 3. A comprehensive outline of all known and potential health
15 and safety risks, including short-term and long-term side effects
16 reported in:
17 a. clinical trials,
18 b. post-market surveillance, including U.S. Department of
19 Health and Human Services and CDC Vaccine Adverse
20 Event Reporting System (VAERS) data,
21 c. information regarding any ethical considerations,
22 including the testing or use of fetal tissue cell
23 lines, animal-derived components, or other materials
24 deemed controversial during development or production,
Req. No. 11357 Page 2
1 d. a clear statement regarding the availability of
2 exemptions under Oklahoma state law for religious,
3 medical, or personal beliefs, and
4 e. information on the National Vaccine Injury
5 Compensation Program (VICP) and patient rights
6 regarding injury claims.
7 B. The written document shall:
8 1. Be provided prior to administration of the vaccine; and
9 2. Include a statement that the patient has the right to
10 accept, decline, or defer the vaccine.
11 C. Health care providers shall:
12 1. Allow the patient sufficient time to review the materials;
13 and
14 2. Answer any questions in a clear and understandable manner
15 regarding vaccine risks, benefits, and ingredients.
16 D. Prior to administering any vaccine, health care providers
17 shall obtain the patient's written informed consent, which shall
18 include acknowledgment of the following:
19 1. Receipt and understanding of the materials provided under
20 subsection A of this section;
21 2. The patient's voluntary decision to accept, decline, or
22 defer the vaccine; and
23 3. Confirmation that the patient has had the opportunity to ask
24 questions and receive answers.
Req. No. 11357 Page 3
1 E. Copies of the signed informed consent forms shall be
2 retained in the patient's medical record for a minimum of seven (7)
3 years.
4 SECTION 3. NEW LAW A new section of law to be codified
5 in the Oklahoma Statutes as Section 7502 of Title 63, unless there
6 is created a duplication in numbering, reads as follows:
7 1. Any health care provider or institution found in violation
8 of this act shall be subject to:
9 a. a civil penalty of up to One Thousand Dollars
10 ($1,000.00) per occurrence for failure to provide the
11 required transparency and disclosure documentation,
12 and
13 b. a civil penalty of up to Five Thousand Dollars
14 ($5,000.00) per occurrence for administering a vaccine
15 without obtaining written informed consent;
16 2. Repeat violations may result in additional penalties,
17 including:
18 a. disciplinary action by the Oklahoma State Board of
19 Medical Licensure and Supervision or other relevant
20 regulatory authorities, and
21 b. suspension or revocation of licenses, where
22 applicable; and
23 3. Patients who believe this act has been violated may:
24
Req. No. 11357 Page 4
1 a. file a formal complaint with the appropriate licensing
2 board, and
3 b. pursue civil action for damages in a court of law.
4 SECTION 4. NEW LAW A new section of law to be codified
5 in the Oklahoma Statutes as Section 7503 of Title 63, unless there
6 is created a duplication in numbering, reads as follows:
7 All documentation, informed consent records, and related
8 materials shall remain confidential and protected under the Health
9 Insurance Portability and Accountability Act (HIPAA) and other
10 relevant state and federal privacy laws.
11 SECTION 5. NEW LAW A new section of law to be codified
12 in the Oklahoma Statutes as Section 7504 of Title 63, unless there
13 is created a duplication in numbering, reads as follows:
14 If any provision of this act is found invalid, the remaining
15 provisions shall remain in full force and effect.
16 SECTION 6. This act shall become effective November 1, 2025.
17
18 60-1-11357 TJ 01/05/25
19
20
21
22
23
24
Req. No. 11357 Page 5
[DELETED:  P B]
[DELETED:  P c p i]
[DELETED:  P a i]
[DELETED:  P a a d s]
[DELETED:  P f p T 0]


================================================================================

Raw Text:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 HOUSE BILL 1079 By: Hildebrant
4
5
6 AS INTRODUCED
7 An Act relating to vaccinations; creating the Vaccine
Transparency and Informed Consent Act; providing the
8 purpose; providing transparency and disclosure
requirements; providing for informed consent
9 standards; providing for civil penalties; requiring
confidentiality of records; providing for
10 severability; providing for codification; and
providing an effective date.
11
12
13
14 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
15 SECTION 1. NEW LAW A new section of law to be codified
16 in the Oklahoma Statutes as Section 7500 of Title 63, unless there
17 is created a duplication in numbering, reads as follows:
18 A. This act shall be known and may be cited as the "Vaccine
19 Transparency and Informed Consent Act".
20 B. The purpose of this act is to ensure transparency in
21 vaccine-related health care practices and to establish informed
22 consent standards by requiring health care providers to disclose
23 comprehensive, evidence-based information regarding vaccines before
24 administration.
Req. No. 11357 Page 1

1 SECTION 2. NEW LAW A new section of law to be codified
2 in the Oklahoma Statutes as Section 7501 of Title 63, unless there
3 is created a duplication in numbering, reads as follows:
4 A. Before administering any vaccine, health care providers
5 shall provide the patient with a written document containing the
6 following:
7 1. A complete list of all ingredients in the vaccine, including
8 active and inactive components, consistent with the Centers for
9 Disease Control and Prevention (CDC) Vaccine Excipient and Media
10 Summary;
11 2. A summary of the testing and development process of the
12 vaccine, including but not limited to, clinical trial phases, study
13 size, and results related to safety and efficacy; and
14 3. A comprehensive outline of all known and potential health
15 and safety risks, including short-term and long-term side effects
16 reported in:
17 a. clinical trials,
18 b. post-market surveillance, including U.S. Department of
19 Health and Human Services and CDC Vaccine Adverse
20 Event Reporting System (VAERS) data,
21 c. information regarding any ethical considerations,
22 including the testing or use of fetal tissue cell
23 lines, animal-derived components, or other materials
24 deemed controversial during development or production,
Req. No. 11357 Page 2

1 d. a clear statement regarding the availability of
2 exemptions under Oklahoma state law for religious,
3 medical, or personal beliefs, and
4 e. information on the National Vaccine Injury
5 Compensation Program (VICP) and patient rights
6 regarding injury claims.
7 B. The written document shall:
8 1. Be provided prior to administration of the vaccine; and
9 2. Include a statement that the patient has the right to
10 accept, decline, or defer the vaccine.
11 C. Health care providers shall:
12 1. Allow the patient sufficient time to review the materials;
13 and
14 2. Answer any questions in a clear and understandable manner
15 regarding vaccine risks, benefits, and ingredients.
16 D. Prior to administering any vaccine, health care providers
17 shall obtain the patient's written informed consent, which shall
18 include acknowledgment of the following:
19 1. Receipt and understanding of the materials provided under
20 subsection A of this section;
21 2. The patient's voluntary decision to accept, decline, or
22 defer the vaccine; and
23 3. Confirmation that the patient has had the opportunity to ask
24 questions and receive answers.
Req. No. 11357 Page 3

1 E. Copies of the signed informed consent forms shall be
2 retained in the patient's medical record for a minimum of seven (7)
3 years.
4 SECTION 3. NEW LAW A new section of law to be codified
5 in the Oklahoma Statutes as Section 7502 of Title 63, unless there
6 is created a duplication in numbering, reads as follows:
7 1. Any health care provider or institution found in violation
8 of this act shall be subject to:
9 a. a civil penalty of up to One Thousand Dollars
10 ($1,000.00) per occurrence for failure to provide the
11 required transparency and disclosure documentation,
12 and
13 b. a civil penalty of up to Five Thousand Dollars
14 ($5,000.00) per occurrence for administering a vaccine
15 without obtaining written informed consent;
16 2. Repeat violations may result in additional penalties,
17 including:
18 a. disciplinary action by the Oklahoma State Board of
19 Medical Licensure and Supervision or other relevant
20 regulatory authorities, and
21 b. suspension or revocation of licenses, where
22 applicable; and
23 3. Patients who believe this act has been violated may:
24
Req. No. 11357 Page 4

1 a. file a formal complaint with the appropriate licensing
2 board, and
3 b. pursue civil action for damages in a court of law.
4 SECTION 4. NEW LAW A new section of law to be codified
5 in the Oklahoma Statutes as Section 7503 of Title 63, unless there
6 is created a duplication in numbering, reads as follows:
7 All documentation, informed consent records, and related
8 materials shall remain confidential and protected under the Health
9 Insurance Portability and Accountability Act (HIPAA) and other
10 relevant state and federal privacy laws.
11 SECTION 5. NEW LAW A new section of law to be codified
12 in the Oklahoma Statutes as Section 7504 of Title 63, unless there
13 is created a duplication in numbering, reads as follows:
14 If any provision of this act is found invalid, the remaining
15 provisions shall remain in full force and effect.
16 SECTION 6. This act shall become effective November 1, 2025.
17
18 60-1-11357 TJ 01/05/25
19
20
21
22
23
24
Req. No. 11357 Page 5

[DELETED:  P B]
[DELETED:  P c p i]
[DELETED:  P a i]
[DELETED:  P a a d s]
[DELETED:  P f p T 0]